Comparison of the basal and glucocorticoid-inducible activities of the upstream regulatory regions of HPV18 and HPV31 in multiple epithelial cell lines

Virology

Volumn 306, Issue 2, 2003, Pages 197-202

  Bromberg White, Jennifer L ^a   Meyers, Craig ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Dexamethasone; Glucocorticoid response element; Human papillomavirus; Upstream regulatory region

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

ARTICLE; CELL LINE; COMPARATIVE STUDY; DNA FLANKING REGION; DNA RESPONSIVE ELEMENT; EPITHELIUM CELL; GENE INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; VIRUS STRAIN; WART VIRUS;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRUS;

EID: 0037440748     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(02)00041-7     Document Type: Article

References (38)

1. Apt D., Watts R., Suske G., Bernard H. High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology. 224:1996;281-291.
2. Baker C., Howley P. Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues. Embo. J. 6:(4):1987;1027-1035.
3. Bauknecht T., Shi Y. Overexpression of C/EBPβ represses human papillomavirus type 18 upstream regulatory region activity in HeLa cells by interfering with the binding of TATA-Binding Protein. J. Virol. 72:(3):1998;2113-2124.
4. Bedell M., Hudson J., Golub T., Turyk M., Hosken M., Wilbanks G., Laimins L. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J. Virol. 65:(5):1991;2254-2260.
5. Boukamp P., Petrussevska R., Breitkreutz D., Hornung J., Markham A., Fusenig R. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:1988;761-771.
6. Brinton L. Oral contraceptives and cervical neoplasia. Contraception. 43:(6):1991;581-595.
7. Bromberg-White J., Meyers C. The upstream regulatory region of HPV31 is insensitive to glucocorticoids. J. Virol. 76:2002;9702-9715.
8. Butz K., Hoppe-Seyler F. Transcriptional control of human papillomavirus (HPV) oncogene expression composition of the HPV type 18 upstream regulatory region . J. Virol. 67:1993;6476-6486.
9. Chan W., Klock G., Bernard H. Progesterone and glucocorticoid response elements occur in the Llong control region of several human papillomaviruses involved in anogenital neoplasia. J. Virol. 63:(8):1989;3261-3269.
10. Chen Y.H., Huang L.H., Chen T.M. Differential effects of progestins and estrogens on long control regions of human papillomavirus types 16 and 18. Biochem. Biophys. Res. Comm. 224:1996;651-659.
11. Chong T., Chan W., Bernard H. Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF a model for the composition of genital papillomavirus enhancers . Nucleic Acids. Res. 18:1990;465-470.
12. Crook T., Wrede D., Vousden K.H. p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene. 6:(5):1991;873-875.
13. Dong X., Pfister H. Overlapping YY1- and aberrant SP1-binding sites proximal to the early promoter of human papillomavirus type 16. J. Gen. Virol. 80:1999;2097-2101.
14. Durst M., Gallahan D., Jay G., Rhim J. Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene. Virology. 173:1989;767-771.
15. Gloss B., Bernard H., Seedorf K., Klock G. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. Embo. J. 6:(12):1987;3735-3743.
16. Gloss B., Yeo-Gloss M., Meisterernst M., Rogge L., Winnacker E.L., Bernard H.U. Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. Nucleic Acids Res. 17:1989;3519-3533.
17. Goldsborough M., DiSilvestre D., Temple G., Lorincz A. Nucleotide sequence of human papillomavirus type 31 a cervical neoplastic-associated virus . Virology. 171:1989;306-311.
18. Grassmann K., Rapp B., Maschek H., Petry K., Iftner T. Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J. Virol. 70:(4):1996;2339-2349.
19. Hildesheim A., Reeves W., Brinton L., Bavery C., Brenes M., De La Guardia M., Go Doy J., Rawls W. Association of oral contraceptive use and human papillomaviruses in invasive cervical cancers. Int. J. Cancer. 45:1990;860-864.
20. Hoppe-Seyler F., Butz K., Zur Hausen H. Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1. J. Virol. 65:1991;5613-5618.
21. Howley, P., 1996. Papillomavirinae: the viruses and their replication, in: Fields, B.a.H., PM (Ed.), Fields Virology, Vol. 2, third ed., Lippincott-Raven Publishers, Philadelphia. pp. 2045-2076.
22. Hubert W.G., Kanaya T., Laimins L.A. DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5′ of the minimal origin. J. Virol. 73:1999;1835-1845.
23. Kanaya T., Kyo S., Laimins L. The 5′ region of the human papillomavirus type 31 upstream regulatory region acts as an enhancer which augments viral early expression through the action of YY1. Virology. 237:1997;159-169.
24. Kyo S., Tam A., Laimins L.A. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors. Virology. 211:1995;184-197.
25. Laimins L. Human papillomaviruses target differentiating epithelia for virion production and malignant conversion. Seminars in Virology. 7:1996;305-313.
26. Medina-Martinez O., Morales-Peza N., Yaniv M., Garcia-Carranca A., Thierry F. A single element mediates glucocotricoid hormone response of HPV18 with no functional interactions with AP1 or hbrm. Virology. 217:1996;392-396.
27. Meyers C., Frattini M., Hudson J., Laimins L. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science. 257:1992;971-973.
28. Meyers C., Mayer T., Ozbun M. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J. Virol. 71:(10):1997;7381-7386.
29. Mittal R., Pater A., Pater M. Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions. J. Virol. 67:1993;5656-5659.
30. Mittal R., Tsutsumi K., Pater A., Pater M. Human papillomavirus type 16 expression in cervical keratinocytes role of progesterone and glucocorticoid hormones . Obstet. Gynecol. 81:1993;5-12.
31. Ozbun M., Meyers C. Transforming growth factor β1 induces differentiation in human papillomavirus-positive keratinocytes. J. Virol. 70:(8):1996;5437-5446.
32. Pater M., Hughes G., Hyslop D., Nakshatri H., Pater A. Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA. Nature. 335:1988;832-835.
33. Rheinwald J.G., Beckett M.A. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res. 41:(5):1981;1657-1663.
34. Sailaja G., Watts R.M., Bernard H.U. Many different papillomaviruses have low transcriptional activity in spite of strong epithelial specific enhancers. J. Gen. Virol. 80:1999;1715-1724.
35. Sen E., Bromberg-White J.L., Meyers C. Genetic analysis of cis regulatory elements within the 5′ region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle. J. Virol. 76:(10):2002;4798-4809.
36. Ursin G., Peters R., Henderson B., D'Ablaing III G., Monroe K., Pike M. Oral contraceptive use and adenocarcinoma of cervix. The Lancet. 344:1994;1390-1394.
37. von Knebel Doeberitz M., Bauknecht T., Bartsch D., zur Hausen H. Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc. Natl. Acad. Sci. USA. 88:1991;1411-1415.
38. Invasive squamous-cell cervical carcinoma and combined oral contraceptives results from a multinational study . Int. J. Cancer. 55:1993;228-236.